Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New HCFA Advisory Panel Recommends Pacemaker APC Be Split Four Ways

This article was originally published in The Gray Sheet

Executive Summary

Ambulatory Payment Classification (APC) 0102 covering electronic analysis of pacemakers and other devices should be split into four different APCs, HHS' Ambulatory Payment Classification Groups advisory panel concluded March 1 at a meeting in Washington, D.C.

You may also be interested in...



CMS Heeds Panel Advice, Modifies Sling Device APCs In OPPS Proposed Rule

Boston Scientific's line of products used to perform sling operations for stress incontinence, including the Capio transvaginal suture capturing device and the Precision Tack and Twist transvaginal anchor systems, will benefit from higher reimbursement rates starting Jan. 1, 2002.

Keeping Track: US FDA's Rejection Of First RMAT BLA Blemishes Otherwise Positive Week Of Non-Oncology News

The latest non-oncology drug development news and highlights from our US FDA Performance Tracker.

UsernamePublicRestriction

Register

MT014570

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel